KAAACI Allergic Rhinitis Guidelines: Part 2. Update in nonpharmacotherapy
10.4168/aard.2023.11.3.126
- Author:
Sang Chul PARK
1
;
Soo Jie CHUNG
;
Jeong-Hee CHOI
;
Yong Ju LEE
;
Hyeon-Jong YANG
;
Do-Yang PARK
;
Dong-Kyu KIM
;
Il Hwan LEE
;
Soo Whan KIM
;
Do Hyun KIM
;
Young Joon JUN
;
Song-I YANG
;
Minji KIM
;
Gwanghui RYU
;
Sung-Yoon KANG
;
Sang Min LEE
;
Mi-Ae KIM
;
Hyun-Jung KIM
;
Gil-Soon CHOI
;
Hyun Jong LEE
;
Hyo-Bin KIM
;
Bong-Seong KIM
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
- Publication Type:REVIEW
- From:Allergy, Asthma & Respiratory Disease
2023;11(3):126-134
- CountryRepublic of Korea
- Language:English
-
Abstract:
Allergic rhinitis is the most common chronic disease worldwide. Various upper airway symptoms lower quality of life, and due to the recurrent symptoms, multiple treatments are usually attempted rather than one definitive treatment. There are alternatives to medical (medication-based) and nonmedical treatments. A guideline is needed to understand allergic rhinitis and develop an appropriate treatment plan. We have developed guidelines for medical treatment based on previous reports. The current guidelines herein are associated with the “KAAACI Evidence-Based Guidelines for Allergic Rhinitis in Korea, Part 1: Update in pharmacotherapy” in which we aimed to provide evidence-based recommendations for the medical treatment of allergic rhinitis. Part 2 focuses on nonpharmacological management, including allergen-specific immunotherapy, subcutaneous or sublingual immunotherapy, nasal saline irrigation, environmental management strategies, companion animal management, and nasal turbinate surgery. The evidence to support the treatment efficacy, safety, and selection has been systematically reviewed. However, larger controlled studies are needed to elevate the level of evidence to select rational non-medical therapeutic options for patients with allergic rhinitis.
